[go: up one dir, main page]

WO2002100843A1 - Phenoxazine compounds, the compositions containing them and their medicinal uses - Google Patents

Phenoxazine compounds, the compositions containing them and their medicinal uses Download PDF

Info

Publication number
WO2002100843A1
WO2002100843A1 PCT/CN2001/000968 CN0100968W WO02100843A1 WO 2002100843 A1 WO2002100843 A1 WO 2002100843A1 CN 0100968 W CN0100968 W CN 0100968W WO 02100843 A1 WO02100843 A1 WO 02100843A1
Authority
WO
WIPO (PCT)
Prior art keywords
compositions containing
medicinal uses
phenoxazine compounds
phenoxazine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000968
Other languages
English (en)
French (fr)
Inventor
Jianqing Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/CN2001/000968 priority Critical patent/WO2002100843A1/zh
Priority to CN01801106A priority patent/CN1366519A/zh
Publication of WO2002100843A1 publication Critical patent/WO2002100843A1/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38—[b, e]-condensed with two six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PCT/CN2001/000968 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses Ceased WO2002100843A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2001/000968 WO2002100843A1 (en) 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses
CN01801106A CN1366519A (zh) 2001-06-13 2001-06-13 吩噁嗪类化合物及其药物组合物和其医药应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000968 WO2002100843A1 (en) 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses

Publications (1)

Publication Number Publication Date
WO2002100843A1 true WO2002100843A1 (en) 2002-12-19

Family

ID=4574812

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000968 Ceased WO2002100843A1 (en) 2001-06-13 2001-06-13 Phenoxazine compounds, the compositions containing them and their medicinal uses

Country Status (2)

Country Link
CN (1) CN1366519A (zh)
WO (1) WO2002100843A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118580A3 (en) * 2004-05-12 2006-08-03 Us Gov Health & Human Serv Tricyclic compounds as inhibitors of the hypoxic signaling pathway
GB2433071A (en) * 2005-12-05 2007-06-13 Kontrakt Technology Ltd Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819423B (zh) * 2014-02-13 2015-04-15 江苏傲伦达科技实业股份有限公司 一种合成n–芳基–吩噁嗪类化合物的方法
CN109512824B (zh) * 2018-11-14 2021-07-16 吉林大学 刃天青在作为牛胰岛素淀粉样纤维抑制剂方面的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156347A2 (de) * 1984-03-29 1985-10-02 Roche Diagnostics GmbH Glycoside von Resorufin-Derivaten, Verfahren zu deren Herstellung sowie deren Verwendung zur Bestimmung der Aktivität von Glycosidasen
CN1086825A (zh) * 1992-08-31 1994-05-18 弗·哈夫曼-拉罗切有限公司 三环和四环化合物
US5498542A (en) * 1994-09-29 1996-03-12 Bayer Corporation Electrode mediators for regeneration of NADH and NADPH

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156347A2 (de) * 1984-03-29 1985-10-02 Roche Diagnostics GmbH Glycoside von Resorufin-Derivaten, Verfahren zu deren Herstellung sowie deren Verwendung zur Bestimmung der Aktivität von Glycosidasen
CN1086825A (zh) * 1992-08-31 1994-05-18 弗·哈夫曼-拉罗切有限公司 三环和四环化合物
US5498542A (en) * 1994-09-29 1996-03-12 Bayer Corporation Electrode mediators for regeneration of NADH and NADPH

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118580A3 (en) * 2004-05-12 2006-08-03 Us Gov Health & Human Serv Tricyclic compounds as inhibitors of the hypoxic signaling pathway
GB2433071A (en) * 2005-12-05 2007-06-13 Kontrakt Technology Ltd Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell

Also Published As

Publication number Publication date
CN1366519A (zh) 2002-08-28

Similar Documents

Publication Publication Date Title
WO2004074266A8 (en) Hiv inhibiting 1,2,4-triazines
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
WO2003018059A3 (de) Kombinationspräparate von arylsubstituierten propanolaminderivaten mit weiteren wirkstoffen und deren verwendung
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
WO2003087050A3 (fr) Sel de perindopril et les compositions pharmaceutiques qui le contiennent
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
IL189270A (en) Repamycins converted to phosphonate and their derivatives, pharmaceutical preparations containing them and their use in the prevention and treatment of bone and joint infections
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
WO2005117895A8 (en) Compositions comprising meloxicam
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
WO2003050067A3 (fr) Analogues de la vitamine d
WO2004056832A3 (en) Epothilone derivatives
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
WO2002100843A1 (en) Phenoxazine compounds, the compositions containing them and their medicinal uses
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 01801106.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP